Breaking News

BioLegacy Research Completes USDA Inspection with Zero Findings

Reaffirms its ongoing commitment to high standards of quality, compliance, and animal welfare.

BioLegacy Research, a contract research organization (CRO) specializing in preclinical services in regulated species, successfully completed its recent USDA inspection, which concluded with zero findings.

The inspection, conducted on September 2, 2025, reaffirms BioLegacy Research’s ongoing commitment to high standards of quality, compliance, and animal welfare. The USDA’s thorough review identified no concerns, underscoring the organization’s dedication to operational excellence and regulatory integrity.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics